(2S,3aS,7aS)-6-oxo-2,3,3a,4,5,6,7,7a-octahydroindole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester | 320748-67-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S,3aS,7aS)-6-oxo-2,3,3a,4,5,6,7,7a-octahydroindole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester
• 英文别名: 1-benzyl 2-methyl (2S,3aS,7aS)-6-oxo-octahydro-1H-indole-1,2-dicarboxylate
• CAS: 320748-67-2
• 化学式: C₁₈H₂₁NO₅
• 分子量: 331.368
• InChiKey: JIIGJFOKMNUVAF-BPUTZDHNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.31
• 重原子数：
  24.0
• 可旋转键数：
  3.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  72.91
• 氢给体数：
  0.0
• 氢受体数：
  5.0

反应信息

• 作为反应物：
  描述：

  (2S,3aS,7aS)-6-oxo-2,3,3a,4,5,6,7,7a-octahydroindole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester 在 palladium on activated charcoal 咪唑 、 氢气 、 L-Selectride 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， -78.0~20.0 ℃ 、101.33 kPa 条件下， 反应 20.0h， 生成
  参考文献：
  名称：

  Total Synthesis and Stereochemical Revision of (+)-Aeruginosin 298-A

  摘要：

  [GRAPHICS]Novel routes toward both enantiomers of the bicyclic proline surrogate 2-carboxy-6-hydroxyoctahydroindole, i.e., Choi, were developed on the basis of the oxidative cyclization of L-tyrosine. Synthesis of the proposed sequence of (+)-aeruginosin 298-A did not provide the natural product. Incorporation of a D-leucine residue, in contrast, led to the total synthesis of this thrombin inhibitor.

  DOI：

  10.1021/ol006759x
• 作为产物：
  描述：

  (2S,7aS)-6-oxo-2,3,5,6,7,7a-hexahydroindole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester 在 platinum(IV) oxide 氢气 作用下， 以 乙醇 、 溶剂黄146 为溶剂， 反应 1.0h， 以95%的产率得到(2S,3aS,7aS)-6-oxo-2,3,3a,4,5,6,7,7a-octahydroindole-1,2-dicarboxylic acid 1-benzyl ester 2-methyl ester
  参考文献：
  名称：

  Total Synthesis and Stereochemical Revision of (+)-Aeruginosin 298-A

  摘要：

  [GRAPHICS]Novel routes toward both enantiomers of the bicyclic proline surrogate 2-carboxy-6-hydroxyoctahydroindole, i.e., Choi, were developed on the basis of the oxidative cyclization of L-tyrosine. Synthesis of the proposed sequence of (+)-aeruginosin 298-A did not provide the natural product. Incorporation of a D-leucine residue, in contrast, led to the total synthesis of this thrombin inhibitor.

  DOI：

  10.1021/ol006759x

文献信息

• [EN] PYRROLIDINE, THIAZOLIDINE AND OXAZOLIDINE COMPOUNDS WHICH INHIBIT DIPEPTIDYL PEPTIDASE-IV (DPP)<br/>[FR] COMPOSE DE PYRROLIDINE, DE THIAZOLIDINE ET D'OXAZOLIDINE INHIBANT LA DIPEPTIDYL-PEPTIDASE-IV (DPP-IV)
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2004111041A1

  公开（公告）日：2004-12-23

  A compound of the formula (I) or a pharmaceutically acceptable salt thereof: [wherein X is cyano or H; Y is CH?2#191, O, S, SO or SO?2# Z is (lower)alkylene, and the like; R1 and R2 are linked together to form (lower)alkylene or (lower)alkenylene, and R3 is H, (lower)alkyl or hydroxy; and the like; and the (lower)alkylene formed by R1 and R2 and the like may be substituted which may be substituted.] Compounds of formula (I) inhibit DPP-IV activity. They are therefore useful in the treatment of conditions mediated by DPP-IV, such as NIDDM.

  化合物的式(I)或其药学上可接受的盐：[其中X是氰基或H; Y是CH?2#191，O，S，SO或SO?2# Z是(较低的)烷基，等等; R1和R2连接在一起形成(较低的)烷基或(较低的)烯基，R3是H，(较低的)烷基或羟基;等等; R1和R2形成的(较低的)烷基和类似物也可以被替代。]式(I)的化合物抑制DPP-IV活性。因此，它们在治疗由DPP-IV介导的疾病，如2型糖尿病方面是有用的。